Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
Authors
Keywords
Immunologic adjuvants, Immune response, Alumni, Elderly, Antigens, Antibody response, Antibodies, Vaccines
Journal
PLoS One
Volume 12, Issue 10, Pages e0186854
Publisher
Public Library of Science (PLoS)
Online
2017-10-27
DOI
10.1371/journal.pone.0186854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
- (2017) Shikhar Mehrotra et al. Journal of Hematology & Oncology
- Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections
- (2017) Tomer Hertz et al. JOURNAL OF IMMUNOLOGY
- Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant
- (2017) Kirsten Schneider-Ohrum et al. JOURNAL OF VIROLOGY
- Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake
- (2017) Frank Liang et al. Science Translational Medicine
- Protection of calves by a prefusion-stabilized bovine RSV F vaccine
- (2017) Baoshan Zhang et al. npj Vaccines
- Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
- (2016) Jeffrey C. Boyington et al. PLoS One
- The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice
- (2015) Frank Wegmann et al. Clinical and Vaccine Immunology
- Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
- (2015) Ki-Hye Kim et al. PLoS One
- Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
- (2015) Christopher A. Green et al. Science Translational Medicine
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
- (2015) Anders Krarup et al. Nature Communications
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
- (2012) Yufei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants
- (2012) Rachel P. J. Lai et al. PLoS One
- A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis
- (2012) Anne L. Hotard et al. VIROLOGY
- An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
- (2012) Anu Cherukuri et al. Immunity & Ageing
- Immunomodulators as adjuvants for vaccines and antimicrobial therapy
- (2010) Erin F. Nicholls et al. Annals of the New York Academy of Sciences
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation
- (2010) Toon Stegmann et al. VACCINE
- Role of adjuvants in modeling the immune response
- (2010) Darrick Carter et al. Current Opinion in HIV and AIDS
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
- (2009) Christiane Stahl-Hennig et al. PLoS Pathogens
- Alum adjuvanticity: Unraveling a century old mystery
- (2008) Ennio De Gregorio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Influenza and respiratory syncytial virus in the elderly
- (2008) Alex J Elliot et al. Expert Review of Vaccines
- New horizons in adjuvants for vaccine development
- (2008) Steven G. Reed et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More